|
Originally published In Press as doi:10.1074/jbc.M205374200 on September 27, 2002
J. Biol. Chem., Vol. 277, Issue 49, 47052-47060, December 6, 2002
DYRK3 Activation, Engagement of Protein Kinase A/cAMP
Response Element-binding Protein, and Modulation of Progenitor Cell
Survival*
Ke
Li,
Shuqing
Zhao,
Vinit
Karur, and
Don M.
Wojchowski
From the Immunobiology Program and the Department of Veterinary
Science, Pennsylvania State University,
University Park, Pennsylvania 16802
DYRKs are a new family of
dual-specificity tyrosine-regulated
kinases with emerging roles in cell growth and development. Recently, we discovered that DYRK3 is expressed primarily in
erythroid progenitor cells and modulates late erythropoiesis. We now
describe 1) roles for the DYRK3 YTY signature motif in kinase
activation, 2) the coupling of DYRK3 to cAMP response element
(CRE)-binding protein (CREB), and 3) effects of DYRK3 on hematopoietic
progenitor cell survival. Regarding the DYRK3 kinase domain, intactness
of Tyr333 (but not Tyr331) within
subdomain loop VII-VIII was critical for activation. Tyr331 plus Tyr333 acidification (Tyr mutated
to Glu) was constitutively activating, but kinase activity was not
affected substantially by unique N- or C-terminal domains. In
transfected 293 and HeLa cells, DYRK3 was discovered to efficiently
stimulate CRE-luciferase expression, to activate a CREB-Gal4
fusion protein, and to promote CREB phosphorylation at
Ser133. Interestingly, this CREB/CRE response was also
supported (50% of wild-type activity) by a kinase-inactive DYRK3
mutant as well as a DYRK3 C-terminal region and was blocked by protein
kinase A inhibitors, suggesting functional interactions between protein kinase A and DYRK3. Finally, DYRK3 expression in
cytokine-dependent hematopoietic FDCW2 cells was observed
to inhibit programmed cell death. Thus, primary new insight into DYRK3
kinase signaling routes, subdomain activities, and possible
biofunctions is provided.
*
This work was supported by National Institutes of Health
Grant RO1 DK40242.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Veterinary
Science, 115 Henning Bldg., Pennsylvania State University, University
Park, PA 16802. Tel.: 814-863-8329; Fax: 814-863-6140; E-mail:
dmw@psu.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Deng, D. Z. Ewton, and E. Friedman
Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen Species
Cancer Res.,
April 15, 2009;
69(8):
3317 - 3324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Bogacheva, O. Bogachev, M. Menon, A. Dev, E. Houde, E. I. Valoret, H. M. Prosser, C. L. Creasy, S. J. Pickering, E. Grau, et al.
DYRK3 Dual-specificity Kinase Attenuates Erythropoiesis during Anemia
J. Biol. Chem.,
December 26, 2008;
283(52):
36665 - 36675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna
DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding
Mol. Biol. Cell,
April 1, 2007;
18(4):
1167 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Deng, S. E. Mercer, S. Shah, D. Z. Ewton, and E. Friedman
The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase
J. Biol. Chem.,
May 21, 2004;
279(21):
22498 - 22504.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|